About Kadimastem
Kadimastem is a company based in Ness Ziona (Israel) founded in 2009.. The company has 11 employees as of December 31, 2024. Kadimastem operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
- Headquarter Ness Ziona, Israel
- Employees 11 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kadimastem Ltd.
-
Annual Revenue
$0 (USD)0as on Dec 31, 2024
-
Net Profit
$-7.28 M (USD)-121.1as on Dec 31, 2024
-
EBITDA
$-1.39 M (USD)42as on Dec 31, 2024
-
Latest Funding Round
$5.01 M (USD), Post-IPO
Oct 25, 2021
-
Investors
European Union
& 8 more
-
Employee Count
11
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Kadimastem
Kadimastem is a publicly listed company on the TASE with ticker symbol KDST in Israel, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of Kadimastem
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $5.0M
-
First Round
First Round
(01 Jan 2016)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2021 | Amount | Post-IPO - Kadimastem | Valuation |
investors |
|
| Oct, 2018 | Amount | Post-IPO - Kadimastem | Valuation |
investors |
|
| Mar, 2018 | Amount | Grant - Kadimastem | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kadimastem
Kadimastem has secured backing from 9 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include European Union, Altshuler Shaham and Clover Wolf Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Diversified investment management services are provided to various clients.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kadimastem
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Kadimastem
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kadimastem Comparisons
Competitors of Kadimastem
Kadimastem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kadimastem
Frequently Asked Questions about Kadimastem
When was Kadimastem founded?
Kadimastem was founded in 2009 and raised its 1st funding round 7 years after it was founded.
Where is Kadimastem located?
Kadimastem is headquartered in Ness Ziona, Israel. It is registered at Ness Ziona, Central District, Israel.
How many employees does Kadimastem have?
As of Dec 31, 2024, the latest employee count at Kadimastem is 11.
What does Kadimastem do?
Founded in 2009 and based in Ness Ziona, Israel, regenerative medicine efforts are directed toward developing and commercializing stem cell-based therapeutics for diabetes mellitus and amyotrophic lateral sclerosis. Proprietary technologies are used to differentiate stem cells into insulin-secreting beta cells and neural cells such as astrocytes and oligodendrocytes. Therapeutic programs are advanced for implantation to address disease progression, with collaborations focused on drug development using pluripotent stem cell-derived cells.
Who are the top competitors of Kadimastem?
Kadimastem's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
Is Kadimastem publicly traded?
Yes, Kadimastem is publicly traded on TASE under the ticker symbol KDST.
Who are Kadimastem's investors?
Kadimastem has 9 investors. Key investors include European Union, Altshuler Shaham, Clover Wolf Capital, Alpha Capital Anstalt, and Yehuda Feinberg.
What is Kadimastem's ticker symbol?
The ticker symbol of Kadimastem is KDST on TASE.